Compound or salt thereof and lipid particles

US12370143B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12370143-B2
Application numberUS-202418443959-A
CountryUS
Kind codeB2
Filing dateFeb 16, 2024
Priority dateJun 8, 2018
Publication dateJul 29, 2025
Grant dateJul 29, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object of the present invention is to provide a compound or a salt thereof constituting lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids, and to provide lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids. According to an aspect of the present invention, a compound represented by Formula (1) or a salt thereof is provided. In the formula, X represents —NR 1 — or —O—, R 1 represents a hydrogen atom, a hydrocarbon group, or the like, R 2 and R 3 each independently represent a hydrogen atom, a hydrocarbon group, or the like, R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 each independently represent a hydrogen atom or an alkyl group, groups in any one or more pairs among R 4 and R 5 , R 10 and R 5 , R 5 and R 12 , R 4 and R 6 , R 5 and R 6 , R 6 and R 7 , R 6 and R 10 , R 12 and R 7 , and R 7 and R 8 may be linked to each other to form a 4- to 7-membered ring which may contain an O atom, a, b, c, and d are each independently represent an integer of 0 to 3, a+b is equal to or greater than 1, and c+d is equal to or greater than 1.

First claim

Opening claim text (preview).

What is claimed is: 1. Lipid particles comprising: a compound represented by Formula (1) or a salt thereof; and a nucleic acid, wherein in the formula, X represents —NR 1 — or —O—, R 1 represents a hydrogen atom, a hydrocarbon group having 6 to 24 carbon atoms, or a group represented by R 21 -L 1 -R 22 —, R 21 represents a hydrocarbon group having 1 to 24 carbon atoms, L 1 represents —O(CO)O—, —O(CO)—, —(CO)O—, —O—, or a group represented by the following formula, R 22 represents a divalent hydrocarbon linking group having 1 to 18 carbon atoms, R 2 and R 3 each independently represent a hydrogen atom, a hydrocarbon group having 3 to 24 carbon atoms, or a group represented by R 31 -L 2 -R 32 —, R 31 represents a hydrocarbon group having 1 to 24 carbon atoms, L 2 represents —O(CO)O—, —O(CO)—, —(CO)O—, —O—, or a group represented by the following formula, R 32 represents a divalent hydrocarbon linking group having 1 to 18 carbon atoms, R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 each independently represent a hydrogen atom or an alkyl group having 1 to 18 carbon atoms that may be substituted, groups in any one or more pairs among R 4 and R 5 , R 10 and R 5 , R 5 and R 12 , R 4 and R 6 , R 5 and R 6 , R 6 and R 7 , R 6 and R 10 , R 12 and R 7 , and R 7 and R 8 may be linked to each other to form a 4- to 7-membered ring which may contain an O atom, a substituent on the alkyl group having 1 to 18 carbon atoms that may be substituted is a hydroxyl group, a carboxyl group, an amino group represented by —NR 45 R 46 , a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, or a group represented by —O(CO)O—R 41 , —O(CO)—R 42 , —(CO)O—R 43 , or —O—R 44 , R 41 , R 42 , R 43 , R 44 , R 45 , and R 46 each independently represent a hydrocarbon group having 1 to 18 carbon atoms, a substituent on the substituted or unsubstituted aryl group and on the substituted or unsubstituted heteroaryl group is an alkyl group having 1 to 18 carbon atoms, a hydroxyl group, a carboxyl group, an amino group represented by —NR 45 R 46 , or a group represented by —O(CO)O—R 41 , —O(CO)—R 42 , —(CO)O—R 43 , or —O—R 44 , R 41 , R 42 , R 43 , R 44 , R 45 , and R 46 each independently represent a hydrocarbon group having 1 to 18 carbon atoms, a, b, c, and d each independently represent an integer of 0 to 3, a+b is equal to or greater than 1, and c+d is equal to or greater than 1. 2. The lipid particles according to claim 1 , further comprising a lipid. 3. The lipid particles according to claim 2 , wherein the lipid is at least one kind of lipid selected from the group consisting of a neutral lipid and a lipid having a nonionic hydrophilic polymer. 4. The lipid particles according to claim 1 , further comprising a sterol. 5. The lipid particles according to claim 1 , wherein X represents —NR 1 —, and R 1 has the same definition as R 1 in claim 1 . 6. The lipid particles according to claim 1 , wherein X represents —NR 1 —, R 1 represents a hydrocarbon group having 6 to 24 carbon atoms, or a group represented by R 21 -L 1 -R 22 —, R 21 , L 1 , and R 22 have the same definitions as R 21 , L 1 , and R 22 in claim 1 respectively; one of R 2 and R 3 represents a hydrogen atom and the other represents a hydrocarbon group having 3 to 24 carbon atoms or a group represented by R 31 -L 2 -R 32 —, and R 31 , L 2 , and R 32 have the same definitions as R 31 , L 2 , and R 32 in claim 1 respectively. 7. The lipid particles according to claim 1 , wherein the compound represented by Formula (1) is a compound represented by Formula (1-1), wherein R 24 represents a hydrogen atom, a hydrocarbon group having 6 to 24 carbon atoms, or a group represented by R 21 -L 1 -R 22 —, R 21 represents a hydrocarbon group having 1 to 24 carbon atoms, L 1 represents —O(CO)O—, —O(CO)—, —(CO)O—, —O—, or a group represented by the following formula, R 22 represents a divalent hydrocarbon linking group having 1 to 18 carbon atoms, R 25 represents a hydrogen atom, a hydrocarbon group having 3 to 24 carbon atoms, or a group represented by R 31 -L 2 -R 32 —, R 31 represents a hydrocarbon group having 1 to 24 carbon atoms, L 2 represents —O(CO)O—, —O(CO)—, —(CO)O—, —O—, or a group represented by the following formula, R 32 represents a divalent hydrocarbon linking group having 1 to 18 carbon atoms, R 4 , R 5 , R 6 , R 7 , R 8 , R 10 , and R 12 each independently represent a hydrogen atom or an alkyl group having 1 to 18 carbon atoms that may be substituted, groups in any one or more pairs among R 4 and R 5 , R 10 and R 5 , R 5 and R 12 , R 4 and R 6 , R 5 and R 6 , R 6 and R 7 , R 6 and R 10 , R 12 and R 7 , and R 7 and R 8 may be linked to each other to form a 4- to 7-membered ring which may contain an O atom, a substituent on the alkyl group having 1 to 18 carbon atoms that may be substituted is a hydroxyl group, a carboxyl group, an amino group represented by —NR 45 R 46 , a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, or a group represented by —O(CO)O—R 41 , —O(CO)—R 42 , —(CO)O—R 43 , or —O—R 44 , R 41 , R 42 , R 43 , R 44 , R 45 , and R 46 each independently represent a hydrocarbon group having 1 to 18 carbon atoms, a substituent on the substituted or unsubstituted aryl group and on the substituted or unsubstituted heteroaryl group is an alkyl group having 1 to 18 carbon atoms, a hydroxyl group, a carboxyl group, an amino group represented by —NR 45 R 46 , or a group represented by —O(CO)O—R 41 , —O(CO)—R 42 , —(CO)O—R 43 , or —O—R 44 , and R 41 , R 42 , R 43 , R 44 , R 45 , and R 46 each independently represent a hydrocarbon group having 1 to 18 carbon atoms. 8. The lipid particles according to claim 1 , wherein X represents —O—. 9. The lipid particles according to claim 1 , wherein X represents —O—, R 2 and R 3 each independently represent a hydrocarbon group having 3 to 24 carbon atoms or a group represented by R 31 -L 2 -R 32 —, and R 31 , L 2 , and R 32 have the same definitions as R 31 , L 2 , and R 32 in claim 1 respectively. 10. The lipid particles according to claim 1 , wherein R 4 , R 6 , R 9 , R 10 , R 11 , and R 12 each represent a hydrogen atom. 11. The lipid particles according to claim 1 , wherein R 2 and R 3 each independently represent a hydrogen atom, a hydrocarbon group having 6 to 24 carbon atoms, or a group represented by R 31 -L 2 -R 32 —. 12. The lipid particles according to claim 1 , wherein X represents —O—, R 2 , R 3 , R 31 , L 2 , and R 32 have the same definitions as R 2 , R 3 , R 31 , L 2 , and R 32 in claim 1 respectively, R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and R 12 each independently represent a hydrogen atom or an alkyl group having 1 to 18 carbon atoms that may be substituted, a substituent on the alkyl group having 1 to 18 carbon atoms that may be su

Assignees

Inventors

Classifications

  • using microencapsulation, e.g. using {amphiphile} liposome vesicle · CPC title

  • having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton · CPC title

  • Post-loading, e.g. by ion or pH gradient · CPC title

  • Compounds having three or more nucleosides or nucleotides · CPC title

  • the non-active part being non-polymeric · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12370143B2 cover?
An object of the present invention is to provide a compound or a salt thereof constituting lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids, and to provide lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids. According to an aspect of the present invention, a compound repre…
Who is the assignee on this patent?
Fujifilm Corp
What technology area does this patent fall under?
Primary CPC classification A61K31/7088. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).